. Overview We are a clinical-stage biotechnology company committed to a bold mission: to discover, develop and deliver potentially curative therapies that address the underlying drivers of heart disease. Heart disease remains the leading cause of death in the world. In the U.S., one person dies from a cardiovascular-related health condition every 34 seconds, a gruesome statistic that translates to one in every three deaths in the U.S each year. One in 20 adults suffer from congenital heart disea...
expected 2026-11-04
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-11 | 2025-12-31 | 0001193125-26-102252 | EDGAR | 95K words |
| 2025-03-10 | 2024-12-31 | 0000950170-25-036329 | EDGAR | 90K words |
| 2024-03-18 | 2023-12-31 | 0000950170-24-032828 | EDGAR | 86K words |
| 2023-03-08 | 2022-12-31 | 0000950170-23-006725 | EDGAR | 103K words |
| 2022-03-23 | 2021-12-31 | 0000950170-22-004426 | EDGAR | 115K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0001193125-26-335140 | EDGAR | 63K words |
| 2025-11-10 | 2025-09-30 | 0001193125-25-273239 | EDGAR | 61K words |
| 2025-08-06 | 2025-06-30 | 0000950170-25-104182 | EDGAR | 61K words |
| 2025-05-07 | 2025-03-31 | 0000950170-25-065741 | EDGAR | 59K words |
| 2024-11-06 | 2024-09-30 | 0000950170-24-122359 | EDGAR | 57K words |
| 2024-08-08 | 2024-06-30 | 0000950170-24-094059 | EDGAR | 57K words |
| 2024-05-14 | 2024-03-31 | 0000950170-24-059576 | EDGAR | 53K words |
| 2023-11-08 | 2023-09-30 | 0000950170-23-061162 | EDGAR | 59K words |
| 2023-08-09 | 2023-06-30 | 0000950170-23-040651 | EDGAR | 58K words |
| 2023-05-10 | 2023-03-31 | 0000950170-23-020609 | EDGAR | 57K words |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024521 | EDGAR | 71K words |
| 2022-08-10 | 2022-06-30 | 0000950170-22-016478 | EDGAR | 69K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-05 | 0001193125-26-335098 | EDGAR | 3K words |
| 2026-03-11 | 0001193125-26-102170 | EDGAR | 3K words |
| 2026-03-05 | 0001193125-26-092654 | EDGAR | 1K words |
| 2026-01-30 | 0001193125-26-032017 | EDGAR | 23K words |
| 2026-01-02 | 0001193125-26-001065 | EDGAR | 1K words |
| 2025-12-12 | 0001193125-25-317642 | EDGAR | 1K words |
| 2025-12-11 | 0001193125-25-315951 | EDGAR | 2K words |
| 2025-11-10 | 0001193125-25-273230 | EDGAR | 3K words |
| 2025-11-07 | 0001193125-25-272423 | EDGAR | 1K words |
| 2025-08-06 | 0000950170-25-104164 | EDGAR | 3K words |
85 total filings indexed. 58 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001858848 |
| Ticker | TNYA |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.tenayatherapeutics.com |
| Listed | 2021-07-30 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/TNYA (~200 tokens, structured JSON with cryptographic provenance)